Furthermore, as a desirable outcome of targeted glucose metabolism for anticancer therapies (Cui et al., 2023), glucose deprivation-induced cell death is more pronounced in gastric cancer cells that overexpress HAP1 (Qu et al., 2023). This evidence concerns the gene HAP1 and gastric cancer.